Compounds > n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide
Page last updated: 2024-09-05

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Liver Diseases

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide has been researched along with Liver Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MORITA, S1
BOCKEL, R; FRICK, A; IMLER, M; KURTZ, D1

Other Studies

2 other study(ies) available for n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Liver Diseases

ArticleYear
[Studies on iron and copper metabolism in liver diseases. 5. Experiments].
    Naika hokan. Japanese archives of internal medicine, 1961, Volume: 8

    Topics: Copper; Cyclic N-Oxides; Humans; Iron; Liver Diseases

1961
[Studies on disorders of ammonia metabolism in liver diseases. 3. Disorders of ammonia metabolism in liver diseases].
    Rontgen- und Laboratoriumspraxis, 1962, Volume: 15

    Topics: Ammonia; Cyclic N-Oxides; Humans; Liver Diseases

1962